Summary
① Approved
Israel（2023）：Skin & Oral SCC
Japan（2026）：Oral Cavity Cancer
② Ongoing Study
1. Skin Cancer
NCT05323253
Update：2025-12-02
Objective：Pivotal Study
Primary/Study Completion：2025-12＊
Enrollment：86＊
Locations：US25 Canada1 Israel4
2. Oral Cavity Cancer
#1 NCT05047094
Update：2026-04-06
Objective：Futility or Efficacy
Study Completion：2027-06＊
Enrollment：48＊
Locations：Israel3
#2 NCT03889899
Update：2025-12-02
Objective：Safety and Efficacy
Study Completion：2026-09＊
Enrollment：30＊
Location：Israel1
3. Breast Cancer
NCT06202118
Update：2025-02-07
Objective：Feasibility and Safety
Primary Completion：2026-01＊
Enrollment：10＊
Locations：Israel1
4. Pancreatic Cancer
#1 NCT04002479
Update：2025-12-02
Objective：Safety and Efficacy
Primary/Study Completion：2026-10＊
Enrollment：37
Locations：Canada2
#2 NCT06698458
Update：2026-05-06
Objective：Feasibility, Safety and Preliminary Efficacy
Primary Completion：2026-10＊
Enrollment：40＊
Locations：US12 Canada1 Israel1
#3 NCT06755359
Update：2025-12-02
Objective：Safety
Condition：Locally Advanced Pancreatic Cancer
Study Start：2026-01＊
Primary Completion：2027-01＊
Study Completion：2027-06＊
Enrollment：40＊
Locations：France12
5. Prostate Cancer
NCT07290998
Update：2026-04-06
Objective：Safety
Study Start：2026-05＊
Primary Completion：2028-05＊
Enrollment：12＊
Locations：No location data
6. Liver Cancer
NCT05829291
Update：2024-05-10
Objective：Feasibility and Safety
Study Completion：2026-02＊
Enrollment：10＊
Locations：Canada1
7. Lung Cancer
NCT05632913
Update：2025-12-02
Objective：Feasibility and Safety
Primary/Study Completion：2027-02＊
Enrollment：10＊
Location：Israel1
8. Brain Tumor
NCT06910306
Update：2026-04-06
Objective：Feasibility and Safety
Study Completion：2026-12-01＊
Enrollment：10＊
Location：US1
9. Vulvar SCC
NCT06202339
Update Posted：2024-01-31
Objective：Feasibility and Safety
Study Completion：2026-12＊
Enrollment：10＊
No location data（EU）
＊Estimated
投資の参考になりましたか？
